News
Biogen Inc. has announced a $2 billion investment to expand its manufacturing capabilities at Research Triangle Park (RTP), ...
Fumarate therapies are equally effective among Black, Hispanic, Asian, and white people with relapsing forms of MS, a real-world study shows.
Coriolis Pharma, headquartered in Martinsried, near Munich, Germany, has about 200 employees worldwide, according to reports.
Modernization of “manufacturing technologies and controls through further advanced automation and artificial intelligence” ...
ALS is a progressive and fatal neurological disorder with no known cure. A new clinic offering treatment raises alarms about ...
1d
Pharmaceutical Technology on MSNBiogen to invest further $2bn in North Carolina’s Research Triangle Park
Biogen has announced plans to invest an additional $2bn in Research Triangle Park (RTP) in the US state of North Carolina.
One of North Carolina’s largest life sciences companies, Biogen Inc. (Nasdaq BIIB), is celebrating its 30th anniversary in the state by announcing that it intends to invest an additional $2 billion at ...
RESEARCH TRIANGLE PARK, N.C. (WTVD) -- Global biotechnology firm Biogen announced a major investment in its Research Triangle Park hub. The company said it will spend $2 billion to expand its North ...
Biogen said it intends to invest an additional $2 billion to expand operations at its largest manufacturing facilities within North Carolina’s Research Triangle Park (RTP).
The drugmaker has invested $10 billion in Wake and Durham counties over the past 30 years. Biogen says that figure will increase.
Presentations on tau to explore its biological role, the development of targeted therapies and biomarkers, and the future integration of these innovations into clinical practice ...
In February 2025, Biogen Inc. (NASDAQ:BIIB) formed a partnership with Stoke Therapeutics to develop zorevunersen for Dravet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results